Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
107,573,681
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
3,067,113
-
Shares change
-
+20,896
-
Total reported value, excl. options
-
$9,659,000
-
Value change
-
+$59,819
-
Number of buys
-
4
-
Number of sells
-
-3
-
Price
-
$3.14
Significant Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) as of Q2 2016
15 filings reported holding VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share as of Q2 2016.
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,067,113 shares
of 107,573,681 outstanding shares and own 2.85% of the company stock.
Largest 10 shareholders include Lagoda Investment Management, L.P. (1,621,274 shares), Southpoint Capital Advisors LP (800,000 shares), Knoll Capital Management, LP (461,538 shares), GEODE CAPITAL MANAGEMENT, LLC (63,662 shares), MORGAN STANLEY (51,900 shares), GOLDMAN SACHS GROUP INC (19,388 shares), GARRISON BRADFORD & ASSOCIATES INC (15,500 shares), National Asset Management, Inc. (12,000 shares), Bank of New York Mellon Corp (10,275 shares), and UBS Group AG (3,603 shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.